Author: Paul Govern
Apr. 29, 2021—Under the SARS CoV-2 Return to School Saliva Opt-in Screening Study, which began last November at University School of Nashville, a research team from Vanderbilt University Medical Center is testing a solution for efficient asymptomatic disease surveillance and control.
Apr. 23, 2021—Vanderbilt University Medical Center (VUMC) is reporting only four persons who have been fully vaccinated against COVID-19 have been diagnosed with COVID during an acute care hospitalization at its facilities over the past four months.
Apr. 21, 2021—A research team from Vanderbilt University Medical Center and institutions across Latin America today reports what looks to be far the largest study to date of life expectancy for people living with HIV infection in low-income or middle-income countries.
Apr. 15, 2021—New research from Vanderbilt University Medical Center, published recently in the journal PLOS Genetics, suggests an essential role for a somewhat obscure biomolecule and casts light on a potential drug target in Alzheimer’s disease.
Apr. 15, 2021—At the start of the COVID-19 pandemic, public health authorities first had to identify and draw attention to common signs and symptoms of the disease.
Apr. 1, 2021—New investments in clinical programs at Vanderbilt University Medical Center are increasingly contingent upon studies to validate claims of benefit and the potential for scalability and spread.
Mar. 25, 2021—Longtime Vanderbilt University School of Medicine faculty member John Zic, MD, MMHC, professor of Dermatology, has been appointed vice chair for Clinical Affairs in the Department of Dermatology and executive medical director of the Dermatology Patient Care Center (PCC) at Vanderbilt University Medical Center.